Mutsumi Tsuchishima
Kanazawa, 9200293, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 28 publications
Pemafibrate modulates peroxisome proliferator-activated receptor alpha and prevents alcohol-associated liver disease in rats.
Journal: Molecular medicine (Cambridge, Mass.)
Published: February 05, 2025
Cellular and molecular mechanisms of hepatic ischemia-reperfusion injury: The role of oxidative stress and therapeutic approaches.
Journal: Redox biology
Published: March 25, 2024
Molecular pathogenesis of metabolic dysfunction-associated steatotic liver disease, steatohepatitis, hepatic fibrosis and liver cirrhosis.
Journal: Journal of cellular and molecular medicine
Published: February 15, 2024
Sonazoid-enhanced ultrasound images of multiacinar cirrhotic nodules showing a "donut-like" hyperintense appearance on Gd-EOB-MRI: a case report.
Journal: Journal of medical ultrasonics (2001)
Published: June 23, 2023
Therapeutic implication of human placental extract to prevent liver cirrhosis in rats with metabolic dysfunction-associated steatohepatitis.
Journal: Clinical science (London, England : 1979)
Published: May 19, 2023
Surgical implantation of human adipose derived stem cells attenuates experimentally induced hepatic fibrosis in rats.
Journal: Molecular medicine (Cambridge, Mass.)
Published: July 26, 2022
Epigallocatechin-3-gallate inhibits osteopontin expression and prevents experimentally induced hepatic fibrosis.
Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Published: April 04, 2022
Novel PKD2 Missense Mutation p.Ile424Ser in an Individual with Multiple Hepatic Cysts: A Case Report.
Journal: Medicines (Basel, Switzerland)
Published: February 12, 2022
Inhibition of γ-glutamyltransferase ameliorates ischaemia-reoxygenation tissue damage in rats with hepatic steatosis.
Journal: British journal of pharmacology
Published: June 02, 2020
Metabolism of N-nitrosodimethylamine, methylation of macromolecules, and development of hepatic fibrosis in rodent models.
Journal: Journal of molecular medicine (Berlin, Germany)
Published: March 04, 2020
Recombinant thrombomodulin prevented hepatic ischemia-reperfusion injury by inhibiting high-mobility group box 1 in rats.
Journal: European journal of pharmacology
Published: May 17, 2019
The combination of fatty liver and increased gamma-glutamyl transpeptidase levels as a risk factor for atherosclerotic plaque development in apparently healthy people
Journal: Turkish journal of medical sciences
Published: January 22, 2019
Last Updated: 09/26/2026